nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—lung cancer	0.332	1	CiPCiCtD
Pemetrexed—Methotrexate—lung cancer	0.213	1	CrCtD
Pemetrexed—TYMS—lung cancer	0.0968	1	CbGaD
Pemetrexed—ATIC—Methotrexate—lung cancer	0.0283	0.201	CbGbCtD
Pemetrexed—Pralatrexate—Methotrexate—lung cancer	0.0282	0.2	CrCrCtD
Pemetrexed—Raltitrexed—Methotrexate—lung cancer	0.0282	0.2	CrCrCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—lung cancer	0.0282	0.2	CrCrCtD
Pemetrexed—Folic Acid—Methotrexate—lung cancer	0.0282	0.2	CrCrCtD
Pemetrexed—Leucovorin—Methotrexate—lung cancer	0.0282	0.2	CrCrCtD
Pemetrexed—SLC29A1—Gemcitabine—lung cancer	0.0229	0.163	CbGbCtD
Pemetrexed—SLC46A1—Methotrexate—lung cancer	0.0225	0.16	CbGbCtD
Pemetrexed—DCK—Gemcitabine—lung cancer	0.0212	0.151	CbGbCtD
Pemetrexed—TYMS—Gemcitabine—lung cancer	0.0212	0.151	CbGbCtD
Pemetrexed—DHFR—Methotrexate—lung cancer	0.0144	0.102	CbGbCtD
Pemetrexed—TYMS—Methotrexate—lung cancer	0.01	0.0712	CbGbCtD
Pemetrexed—ATIC—mammary gland—lung cancer	0.000807	0.0652	CbGeAlD
Pemetrexed—GART—respiratory system—lung cancer	0.000792	0.064	CbGeAlD
Pemetrexed—GART—bronchus—lung cancer	0.000652	0.0526	CbGeAlD
Pemetrexed—GART—trachea—lung cancer	0.000585	0.0473	CbGeAlD
Pemetrexed—GART—cardiac atrium—lung cancer	0.00055	0.0444	CbGeAlD
Pemetrexed—ATIC—respiratory system—lung cancer	0.000538	0.0434	CbGeAlD
Pemetrexed—SLC29A1—mammary gland—lung cancer	0.000491	0.0396	CbGeAlD
Pemetrexed—GART—bone marrow—lung cancer	0.000464	0.0375	CbGeAlD
Pemetrexed—ATIC—epithelium—lung cancer	0.000449	0.0363	CbGeAlD
Pemetrexed—GART—lung—lung cancer	0.00042	0.034	CbGeAlD
Pemetrexed—TYMS—respiratory system—lung cancer	0.000365	0.0295	CbGeAlD
Pemetrexed—DHFR—respiratory system—lung cancer	0.000361	0.0292	CbGeAlD
Pemetrexed—SLC29A1—respiratory system—lung cancer	0.000327	0.0264	CbGeAlD
Pemetrexed—TYMS—bronchus—lung cancer	0.0003	0.0242	CbGeAlD
Pemetrexed—DHFR—bronchus—lung cancer	0.000297	0.024	CbGeAlD
Pemetrexed—GART—lymph node—lung cancer	0.000288	0.0232	CbGeAlD
Pemetrexed—ATIC—lung—lung cancer	0.000285	0.0231	CbGeAlD
Pemetrexed—SLC29A1—bronchus—lung cancer	0.000269	0.0217	CbGeAlD
Pemetrexed—DHFR—trachea—lung cancer	0.000267	0.0216	CbGeAlD
Pemetrexed—DCK—bronchus—lung cancer	0.000257	0.0208	CbGeAlD
Pemetrexed—DHFR—cardiac atrium—lung cancer	0.000251	0.0202	CbGeAlD
Pemetrexed—SLC29A1—trachea—lung cancer	0.000242	0.0195	CbGeAlD
Pemetrexed—SLC46A1—lymph node—lung cancer	0.000233	0.0189	CbGeAlD
Pemetrexed—DCK—trachea—lung cancer	0.000231	0.0186	CbGeAlD
Pemetrexed—SLC29A1—cardiac atrium—lung cancer	0.000227	0.0183	CbGeAlD
Pemetrexed—Raltitrexed—TYMS—lung cancer	0.000218	0.174	CrCbGaD
Pemetrexed—DCK—cardiac atrium—lung cancer	0.000217	0.0175	CbGeAlD
Pemetrexed—TYMS—bone marrow—lung cancer	0.000214	0.0173	CbGeAlD
Pemetrexed—DHFR—bone marrow—lung cancer	0.000212	0.0171	CbGeAlD
Pemetrexed—Leucovorin—ABCC3—lung cancer	0.000207	0.165	CrCbGaD
Pemetrexed—ATIC—lymph node—lung cancer	0.000195	0.0158	CbGeAlD
Pemetrexed—TYMS—lung—lung cancer	0.000194	0.0156	CbGeAlD
Pemetrexed—DHFR—lung—lung cancer	0.000192	0.0155	CbGeAlD
Pemetrexed—SLC29A1—bone marrow—lung cancer	0.000192	0.0155	CbGeAlD
Pemetrexed—DCK—bone marrow—lung cancer	0.000183	0.0148	CbGeAlD
Pemetrexed—SLC29A1—lung—lung cancer	0.000174	0.014	CbGeAlD
Pemetrexed—DCK—lung—lung cancer	0.000166	0.0134	CbGeAlD
Pemetrexed—Pralatrexate—TYMS—lung cancer	0.000165	0.132	CrCbGaD
Pemetrexed—Leucovorin—TYMS—lung cancer	0.000165	0.132	CrCbGaD
Pemetrexed—TYMS—Docetaxel—Paclitaxel—lung cancer	0.000138	0.152	CbGdCrCtD
Pemetrexed—Folic Acid—ABCC3—lung cancer	0.000133	0.107	CrCbGaD
Pemetrexed—TYMS—lymph node—lung cancer	0.000132	0.0107	CbGeAlD
Pemetrexed—DHFR—lymph node—lung cancer	0.000131	0.0106	CbGeAlD
Pemetrexed—DCK—Topotecan—Irinotecan—lung cancer	0.00013	0.144	CbGdCrCtD
Pemetrexed—SLC29A1—lymph node—lung cancer	0.000119	0.00959	CbGeAlD
Pemetrexed—DCK—lymph node—lung cancer	0.000113	0.00916	CbGeAlD
Pemetrexed—TYMS—Erlotinib—Gefitinib—lung cancer	0.000103	0.114	CbGdCrCtD
Pemetrexed—Methotrexate—ABCC3—lung cancer	9.11e-05	0.0729	CrCbGaD
Pemetrexed—TYMS—Podofilox—Teniposide—lung cancer	7.44e-05	0.0821	CbGdCrCtD
Pemetrexed—Methotrexate—TYMS—lung cancer	7.27e-05	0.0582	CrCbGaD
Pemetrexed—TYMS—Paclitaxel—Docetaxel—lung cancer	6.89e-05	0.076	CbGdCrCtD
Pemetrexed—TYMS—Afatinib—Gefitinib—lung cancer	6.74e-05	0.0744	CbGdCrCtD
Pemetrexed—TYMS—Gefitinib—Erlotinib—lung cancer	6.61e-05	0.0729	CbGdCrCtD
Pemetrexed—Folic Acid—ABCG2—lung cancer	6.47e-05	0.0518	CrCbGaD
Pemetrexed—Folic Acid—CYP2E1—lung cancer	5.14e-05	0.0411	CrCbGaD
Pemetrexed—TYMS—Vincristine—Vinorelbine—lung cancer	4.73e-05	0.0523	CbGdCrCtD
Pemetrexed—Methotrexate—ABCG2—lung cancer	4.43e-05	0.0354	CrCbGaD
Pemetrexed—TYMS—Vinorelbine—Vinblastine—lung cancer	4.43e-05	0.0489	CbGdCrCtD
Pemetrexed—TYMS—Podofilox—Etoposide—lung cancer	4.42e-05	0.0488	CbGdCrCtD
Pemetrexed—TYMS—Vinblastine—Vinorelbine—lung cancer	3.81e-05	0.042	CbGdCrCtD
Pemetrexed—TYMS—Vincristine—Vinblastine—lung cancer	3.78e-05	0.0418	CbGdCrCtD
Pemetrexed—DCK—Epirubicin—Doxorubicin—lung cancer	2.83e-05	0.0313	CbGdCrCtD
Pemetrexed—Methotrexate—ALB—lung cancer	1.93e-05	0.0155	CrCbGaD
Pemetrexed—Methotrexate—ABCB1—lung cancer	1.84e-05	0.0147	CrCbGaD
Pemetrexed—Pancytopenia—Methotrexate—lung cancer	1.82e-05	0.000436	CcSEcCtD
Pemetrexed—Anaphylactic shock—Etoposide—lung cancer	1.82e-05	0.000436	CcSEcCtD
Pemetrexed—Mood swings—Doxorubicin—lung cancer	1.82e-05	0.000436	CcSEcCtD
Pemetrexed—Diarrhoea—Vinorelbine—lung cancer	1.82e-05	0.000435	CcSEcCtD
Pemetrexed—Dysgeusia—Docetaxel—lung cancer	1.82e-05	0.000435	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Cisplatin—lung cancer	1.81e-05	0.000434	CcSEcCtD
Pemetrexed—Infection—Etoposide—lung cancer	1.81e-05	0.000433	CcSEcCtD
Pemetrexed—Blood creatinine increased—Doxorubicin—lung cancer	1.8e-05	0.000431	CcSEcCtD
Pemetrexed—Neutropenia—Methotrexate—lung cancer	1.8e-05	0.00043	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Irinotecan—lung cancer	1.79e-05	0.000429	CcSEcCtD
Pemetrexed—Dehydration—Doxorubicin—lung cancer	1.79e-05	0.000428	CcSEcCtD
Pemetrexed—Anaphylactic shock—Paclitaxel—lung cancer	1.79e-05	0.000428	CcSEcCtD
Pemetrexed—Oedema—Paclitaxel—lung cancer	1.79e-05	0.000428	CcSEcCtD
Pemetrexed—Thrombocytopenia—Etoposide—lung cancer	1.79e-05	0.000427	CcSEcCtD
Pemetrexed—TYMS—Azacitidine—Gemcitabine—lung cancer	1.78e-05	0.0197	CbGdCrCtD
Pemetrexed—Infection—Paclitaxel—lung cancer	1.78e-05	0.000425	CcSEcCtD
Pemetrexed—Dyspnoea—Cisplatin—lung cancer	1.78e-05	0.000425	CcSEcCtD
Pemetrexed—Skin disorder—Etoposide—lung cancer	1.77e-05	0.000424	CcSEcCtD
Pemetrexed—Shock—Paclitaxel—lung cancer	1.76e-05	0.000421	CcSEcCtD
Pemetrexed—Dizziness—Vinorelbine—lung cancer	1.76e-05	0.000421	CcSEcCtD
Pemetrexed—Nervous system disorder—Paclitaxel—lung cancer	1.75e-05	0.00042	CcSEcCtD
Pemetrexed—Thrombocytopenia—Paclitaxel—lung cancer	1.75e-05	0.000419	CcSEcCtD
Pemetrexed—Anorexia—Etoposide—lung cancer	1.74e-05	0.000416	CcSEcCtD
Pemetrexed—Skin disorder—Paclitaxel—lung cancer	1.74e-05	0.000416	CcSEcCtD
Pemetrexed—Abdominal pain—Irinotecan—lung cancer	1.73e-05	0.000415	CcSEcCtD
Pemetrexed—Body temperature increased—Irinotecan—lung cancer	1.73e-05	0.000415	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Doxorubicin—lung cancer	1.73e-05	0.000415	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Doxorubicin—lung cancer	1.73e-05	0.000415	CcSEcCtD
Pemetrexed—Decreased appetite—Cisplatin—lung cancer	1.73e-05	0.000414	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Cisplatin—lung cancer	1.72e-05	0.000411	CcSEcCtD
Pemetrexed—Anaemia—Docetaxel—lung cancer	1.72e-05	0.000411	CcSEcCtD
Pemetrexed—Infestation NOS—Methotrexate—lung cancer	1.71e-05	0.00041	CcSEcCtD
Pemetrexed—Infestation—Methotrexate—lung cancer	1.71e-05	0.00041	CcSEcCtD
Pemetrexed—Anorexia—Paclitaxel—lung cancer	1.7e-05	0.000408	CcSEcCtD
Pemetrexed—Pain—Cisplatin—lung cancer	1.7e-05	0.000407	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Methotrexate—lung cancer	1.7e-05	0.000406	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Doxorubicin—lung cancer	1.7e-05	0.000406	CcSEcCtD
Pemetrexed—Vomiting—Vinorelbine—lung cancer	1.69e-05	0.000404	CcSEcCtD
Pemetrexed—Body temperature increased—Gemcitabine—lung cancer	1.69e-05	0.000404	CcSEcCtD
Pemetrexed—Renal failure—Methotrexate—lung cancer	1.68e-05	0.000403	CcSEcCtD
Pemetrexed—Rash—Vinorelbine—lung cancer	1.68e-05	0.000401	CcSEcCtD
Pemetrexed—Dermatitis—Vinorelbine—lung cancer	1.68e-05	0.000401	CcSEcCtD
Pemetrexed—Stomatitis—Methotrexate—lung cancer	1.67e-05	0.000399	CcSEcCtD
Pemetrexed—Syncope—Docetaxel—lung cancer	1.67e-05	0.000398	CcSEcCtD
Pemetrexed—Conjunctivitis—Methotrexate—lung cancer	1.67e-05	0.000398	CcSEcCtD
Pemetrexed—Dysphagia—Doxorubicin—lung cancer	1.66e-05	0.000398	CcSEcCtD
Pemetrexed—Leukopenia—Docetaxel—lung cancer	1.66e-05	0.000398	CcSEcCtD
Pemetrexed—Loss of consciousness—Docetaxel—lung cancer	1.63e-05	0.000391	CcSEcCtD
Pemetrexed—Pancreatitis—Doxorubicin—lung cancer	1.63e-05	0.00039	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Paclitaxel—lung cancer	1.63e-05	0.00039	CcSEcCtD
Pemetrexed—Dyspnoea—Etoposide—lung cancer	1.63e-05	0.000389	CcSEcCtD
Pemetrexed—Angina pectoris—Doxorubicin—lung cancer	1.62e-05	0.000388	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Methotrexate—lung cancer	1.62e-05	0.000388	CcSEcCtD
Pemetrexed—Hypersensitivity—Irinotecan—lung cancer	1.62e-05	0.000386	CcSEcCtD
Pemetrexed—Hypertension—Docetaxel—lung cancer	1.6e-05	0.000384	CcSEcCtD
Pemetrexed—Agranulocytosis—Methotrexate—lung cancer	1.6e-05	0.000382	CcSEcCtD
Pemetrexed—Dyspnoea—Paclitaxel—lung cancer	1.59e-05	0.000381	CcSEcCtD
Pemetrexed—Decreased appetite—Etoposide—lung cancer	1.59e-05	0.000379	CcSEcCtD
Pemetrexed—Myalgia—Docetaxel—lung cancer	1.58e-05	0.000378	CcSEcCtD
Pemetrexed—Arthralgia—Docetaxel—lung cancer	1.58e-05	0.000378	CcSEcCtD
Pemetrexed—Chest pain—Docetaxel—lung cancer	1.58e-05	0.000378	CcSEcCtD
Pemetrexed—Pancytopenia—Doxorubicin—lung cancer	1.58e-05	0.000378	CcSEcCtD
Pemetrexed—Nausea—Vinorelbine—lung cancer	1.58e-05	0.000378	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Etoposide—lung cancer	1.57e-05	0.000377	CcSEcCtD
Pemetrexed—Dyspepsia—Paclitaxel—lung cancer	1.57e-05	0.000377	CcSEcCtD
Pemetrexed—Body temperature increased—Cisplatin—lung cancer	1.57e-05	0.000377	CcSEcCtD
Pemetrexed—Asthenia—Irinotecan—lung cancer	1.57e-05	0.000376	CcSEcCtD
Pemetrexed—Fatigue—Etoposide—lung cancer	1.57e-05	0.000376	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	1.57e-05	0.000376	CcSEcCtD
Pemetrexed—Pain—Etoposide—lung cancer	1.56e-05	0.000373	CcSEcCtD
Pemetrexed—Constipation—Etoposide—lung cancer	1.56e-05	0.000373	CcSEcCtD
Pemetrexed—Neutropenia—Doxorubicin—lung cancer	1.56e-05	0.000372	CcSEcCtD
Pemetrexed—Decreased appetite—Paclitaxel—lung cancer	1.55e-05	0.000372	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Paclitaxel—lung cancer	1.54e-05	0.000369	CcSEcCtD
Pemetrexed—Fatigue—Paclitaxel—lung cancer	1.54e-05	0.000369	CcSEcCtD
Pemetrexed—Hepatitis—Methotrexate—lung cancer	1.54e-05	0.000368	CcSEcCtD
Pemetrexed—Asthenia—Gemcitabine—lung cancer	1.53e-05	0.000367	CcSEcCtD
Pemetrexed—Pain—Paclitaxel—lung cancer	1.53e-05	0.000366	CcSEcCtD
Pemetrexed—Constipation—Paclitaxel—lung cancer	1.53e-05	0.000366	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—lung cancer	1.53e-05	0.000365	CcSEcCtD
Pemetrexed—Urinary tract disorder—Methotrexate—lung cancer	1.52e-05	0.000363	CcSEcCtD
Pemetrexed—Anaphylactic shock—Docetaxel—lung cancer	1.52e-05	0.000363	CcSEcCtD
Pemetrexed—Oedema—Docetaxel—lung cancer	1.52e-05	0.000363	CcSEcCtD
Pemetrexed—Pruritus—Gemcitabine—lung cancer	1.51e-05	0.000362	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—lung cancer	1.51e-05	0.000361	CcSEcCtD
Pemetrexed—Infection—Docetaxel—lung cancer	1.51e-05	0.00036	CcSEcCtD
Pemetrexed—Diarrhoea—Irinotecan—lung cancer	1.5e-05	0.000359	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Etoposide—lung cancer	1.49e-05	0.000357	CcSEcCtD
Pemetrexed—Shock—Docetaxel—lung cancer	1.49e-05	0.000357	CcSEcCtD
Pemetrexed—Nervous system disorder—Docetaxel—lung cancer	1.49e-05	0.000356	CcSEcCtD
Pemetrexed—Thrombocytopenia—Docetaxel—lung cancer	1.48e-05	0.000355	CcSEcCtD
Pemetrexed—Infestation—Doxorubicin—lung cancer	1.48e-05	0.000355	CcSEcCtD
Pemetrexed—Infestation NOS—Doxorubicin—lung cancer	1.48e-05	0.000355	CcSEcCtD
Pemetrexed—Skin disorder—Docetaxel—lung cancer	1.47e-05	0.000352	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Doxorubicin—lung cancer	1.47e-05	0.000352	CcSEcCtD
Pemetrexed—Hypersensitivity—Cisplatin—lung cancer	1.47e-05	0.000351	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Paclitaxel—lung cancer	1.46e-05	0.00035	CcSEcCtD
Pemetrexed—Diarrhoea—Gemcitabine—lung cancer	1.46e-05	0.00035	CcSEcCtD
Pemetrexed—Renal failure—Doxorubicin—lung cancer	1.46e-05	0.000349	CcSEcCtD
Pemetrexed—Erythema multiforme—Methotrexate—lung cancer	1.45e-05	0.000348	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Doxorubicin—lung cancer	1.45e-05	0.000348	CcSEcCtD
Pemetrexed—Dizziness—Irinotecan—lung cancer	1.45e-05	0.000347	CcSEcCtD
Pemetrexed—Urticaria—Etoposide—lung cancer	1.45e-05	0.000347	CcSEcCtD
Pemetrexed—Stomatitis—Doxorubicin—lung cancer	1.45e-05	0.000346	CcSEcCtD
Pemetrexed—Anorexia—Docetaxel—lung cancer	1.45e-05	0.000346	CcSEcCtD
Pemetrexed—Abdominal pain—Etoposide—lung cancer	1.44e-05	0.000345	CcSEcCtD
Pemetrexed—Body temperature increased—Etoposide—lung cancer	1.44e-05	0.000345	CcSEcCtD
Pemetrexed—Conjunctivitis—Doxorubicin—lung cancer	1.44e-05	0.000345	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—lung cancer	1.44e-05	0.000344	CcSEcCtD
Pemetrexed—Asthenia—Cisplatin—lung cancer	1.43e-05	0.000342	CcSEcCtD
Pemetrexed—Urticaria—Paclitaxel—lung cancer	1.42e-05	0.00034	CcSEcCtD
Pemetrexed—Abdominal pain—Paclitaxel—lung cancer	1.41e-05	0.000338	CcSEcCtD
Pemetrexed—Body temperature increased—Paclitaxel—lung cancer	1.41e-05	0.000338	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Doxorubicin—lung cancer	1.4e-05	0.000336	CcSEcCtD
Pemetrexed—Vomiting—Irinotecan—lung cancer	1.39e-05	0.000334	CcSEcCtD
Pemetrexed—Agranulocytosis—Doxorubicin—lung cancer	1.38e-05	0.000331	CcSEcCtD
Pemetrexed—Rash—Irinotecan—lung cancer	1.38e-05	0.000331	CcSEcCtD
Pemetrexed—Dermatitis—Irinotecan—lung cancer	1.38e-05	0.00033	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Docetaxel—lung cancer	1.38e-05	0.00033	CcSEcCtD
Pemetrexed—Diarrhoea—Cisplatin—lung cancer	1.36e-05	0.000326	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—lung cancer	1.36e-05	0.000325	CcSEcCtD
Pemetrexed—Vomiting—Gemcitabine—lung cancer	1.36e-05	0.000325	CcSEcCtD
Pemetrexed—Dyspnoea—Docetaxel—lung cancer	1.35e-05	0.000323	CcSEcCtD
Pemetrexed—Rash—Gemcitabine—lung cancer	1.35e-05	0.000322	CcSEcCtD
Pemetrexed—Dermatitis—Gemcitabine—lung cancer	1.35e-05	0.000322	CcSEcCtD
Pemetrexed—Hypersensitivity—Etoposide—lung cancer	1.34e-05	0.000321	CcSEcCtD
Pemetrexed—Erythema—Methotrexate—lung cancer	1.34e-05	0.00032	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—lung cancer	1.34e-05	0.00032	CcSEcCtD
Pemetrexed—Dyspepsia—Docetaxel—lung cancer	1.33e-05	0.000319	CcSEcCtD
Pemetrexed—Hepatitis—Doxorubicin—lung cancer	1.33e-05	0.000319	CcSEcCtD
Pemetrexed—Pharyngitis—Doxorubicin—lung cancer	1.32e-05	0.000316	CcSEcCtD
Pemetrexed—Decreased appetite—Docetaxel—lung cancer	1.32e-05	0.000315	CcSEcCtD
Pemetrexed—Hypersensitivity—Paclitaxel—lung cancer	1.32e-05	0.000315	CcSEcCtD
Pemetrexed—Urinary tract disorder—Doxorubicin—lung cancer	1.32e-05	0.000315	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—lung cancer	1.31e-05	0.000314	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Docetaxel—lung cancer	1.31e-05	0.000313	CcSEcCtD
Pemetrexed—Asthenia—Etoposide—lung cancer	1.31e-05	0.000313	CcSEcCtD
Pemetrexed—Fatigue—Docetaxel—lung cancer	1.31e-05	0.000313	CcSEcCtD
Pemetrexed—Urethral disorder—Doxorubicin—lung cancer	1.31e-05	0.000312	CcSEcCtD
Pemetrexed—Nausea—Irinotecan—lung cancer	1.3e-05	0.000312	CcSEcCtD
Pemetrexed—Pain—Docetaxel—lung cancer	1.3e-05	0.00031	CcSEcCtD
Pemetrexed—Constipation—Docetaxel—lung cancer	1.3e-05	0.00031	CcSEcCtD
Pemetrexed—Pruritus—Etoposide—lung cancer	1.29e-05	0.000309	CcSEcCtD
Pemetrexed—Asthenia—Paclitaxel—lung cancer	1.28e-05	0.000307	CcSEcCtD
Pemetrexed—Nausea—Gemcitabine—lung cancer	1.27e-05	0.000304	CcSEcCtD
Pemetrexed—Vomiting—Cisplatin—lung cancer	1.27e-05	0.000303	CcSEcCtD
Pemetrexed—Pruritus—Paclitaxel—lung cancer	1.27e-05	0.000303	CcSEcCtD
Pemetrexed—Erythema multiforme—Doxorubicin—lung cancer	1.26e-05	0.000301	CcSEcCtD
Pemetrexed—Rash—Cisplatin—lung cancer	1.26e-05	0.0003	CcSEcCtD
Pemetrexed—Dermatitis—Cisplatin—lung cancer	1.25e-05	0.0003	CcSEcCtD
Pemetrexed—Diarrhoea—Etoposide—lung cancer	1.25e-05	0.000299	CcSEcCtD
Pemetrexed—Eye disorder—Doxorubicin—lung cancer	1.24e-05	0.000298	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Docetaxel—lung cancer	1.24e-05	0.000297	CcSEcCtD
Pemetrexed—Anaemia—Methotrexate—lung cancer	1.24e-05	0.000296	CcSEcCtD
Pemetrexed—Diarrhoea—Paclitaxel—lung cancer	1.22e-05	0.000293	CcSEcCtD
Pemetrexed—Dizziness—Etoposide—lung cancer	1.21e-05	0.000289	CcSEcCtD
Pemetrexed—Body temperature increased—Docetaxel—lung cancer	1.2e-05	0.000287	CcSEcCtD
Pemetrexed—Abdominal pain—Docetaxel—lung cancer	1.2e-05	0.000287	CcSEcCtD
Pemetrexed—Leukopenia—Methotrexate—lung cancer	1.2e-05	0.000287	CcSEcCtD
Pemetrexed—Arrhythmia—Doxorubicin—lung cancer	1.19e-05	0.000285	CcSEcCtD
Pemetrexed—Dizziness—Paclitaxel—lung cancer	1.18e-05	0.000283	CcSEcCtD
Pemetrexed—Nausea—Cisplatin—lung cancer	1.18e-05	0.000283	CcSEcCtD
Pemetrexed—Alopecia—Doxorubicin—lung cancer	1.18e-05	0.000281	CcSEcCtD
Pemetrexed—Vomiting—Etoposide—lung cancer	1.16e-05	0.000277	CcSEcCtD
Pemetrexed—Erythema—Doxorubicin—lung cancer	1.16e-05	0.000277	CcSEcCtD
Pemetrexed—Malnutrition—Doxorubicin—lung cancer	1.16e-05	0.000277	CcSEcCtD
Pemetrexed—Rash—Etoposide—lung cancer	1.15e-05	0.000275	CcSEcCtD
Pemetrexed—Dermatitis—Etoposide—lung cancer	1.15e-05	0.000275	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—lung cancer	1.14e-05	0.000273	CcSEcCtD
Pemetrexed—Arthralgia—Methotrexate—lung cancer	1.14e-05	0.000273	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—lung cancer	1.14e-05	0.000273	CcSEcCtD
Pemetrexed—Vomiting—Paclitaxel—lung cancer	1.14e-05	0.000272	CcSEcCtD
Pemetrexed—Dysgeusia—Doxorubicin—lung cancer	1.14e-05	0.000272	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.13e-05	0.000271	CcSEcCtD
Pemetrexed—Rash—Paclitaxel—lung cancer	1.13e-05	0.00027	CcSEcCtD
Pemetrexed—Dermatitis—Paclitaxel—lung cancer	1.13e-05	0.00027	CcSEcCtD
Pemetrexed—Hypersensitivity—Docetaxel—lung cancer	1.12e-05	0.000267	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—lung cancer	1.09e-05	0.000261	CcSEcCtD
Pemetrexed—Asthenia—Docetaxel—lung cancer	1.09e-05	0.00026	CcSEcCtD
Pemetrexed—Infection—Methotrexate—lung cancer	1.09e-05	0.00026	CcSEcCtD
Pemetrexed—Nausea—Etoposide—lung cancer	1.08e-05	0.000259	CcSEcCtD
Pemetrexed—Pruritus—Docetaxel—lung cancer	1.07e-05	0.000257	CcSEcCtD
Pemetrexed—Nervous system disorder—Methotrexate—lung cancer	1.07e-05	0.000256	CcSEcCtD
Pemetrexed—Anaemia—Doxorubicin—lung cancer	1.07e-05	0.000256	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—lung cancer	1.07e-05	0.000256	CcSEcCtD
Pemetrexed—Nausea—Paclitaxel—lung cancer	1.06e-05	0.000254	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—lung cancer	1.06e-05	0.000254	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—lung cancer	1.04e-05	0.000249	CcSEcCtD
Pemetrexed—Syncope—Doxorubicin—lung cancer	1.04e-05	0.000249	CcSEcCtD
Pemetrexed—Leukopenia—Doxorubicin—lung cancer	1.04e-05	0.000248	CcSEcCtD
Pemetrexed—Diarrhoea—Docetaxel—lung cancer	1.04e-05	0.000248	CcSEcCtD
Pemetrexed—Loss of consciousness—Doxorubicin—lung cancer	1.02e-05	0.000244	CcSEcCtD
Pemetrexed—Dizziness—Docetaxel—lung cancer	1e-05	0.00024	CcSEcCtD
Pemetrexed—Hypertension—Doxorubicin—lung cancer	1e-05	0.000239	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—lung cancer	9.95e-06	0.000238	CcSEcCtD
Pemetrexed—Myalgia—Doxorubicin—lung cancer	9.87e-06	0.000236	CcSEcCtD
Pemetrexed—Chest pain—Doxorubicin—lung cancer	9.87e-06	0.000236	CcSEcCtD
Pemetrexed—Arthralgia—Doxorubicin—lung cancer	9.87e-06	0.000236	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	9.8e-06	0.000234	CcSEcCtD
Pemetrexed—Dyspnoea—Methotrexate—lung cancer	9.74e-06	0.000233	CcSEcCtD
Pemetrexed—Vomiting—Docetaxel—lung cancer	9.64e-06	0.000231	CcSEcCtD
Pemetrexed—Dyspepsia—Methotrexate—lung cancer	9.62e-06	0.00023	CcSEcCtD
Pemetrexed—Rash—Docetaxel—lung cancer	9.56e-06	0.000229	CcSEcCtD
Pemetrexed—Dermatitis—Docetaxel—lung cancer	9.55e-06	0.000228	CcSEcCtD
Pemetrexed—Decreased appetite—Methotrexate—lung cancer	9.5e-06	0.000227	CcSEcCtD
Pemetrexed—Anaphylactic shock—Doxorubicin—lung cancer	9.46e-06	0.000226	CcSEcCtD
Pemetrexed—Oedema—Doxorubicin—lung cancer	9.46e-06	0.000226	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Methotrexate—lung cancer	9.43e-06	0.000226	CcSEcCtD
Pemetrexed—Fatigue—Methotrexate—lung cancer	9.42e-06	0.000225	CcSEcCtD
Pemetrexed—Infection—Doxorubicin—lung cancer	9.4e-06	0.000225	CcSEcCtD
Pemetrexed—Pain—Methotrexate—lung cancer	9.34e-06	0.000224	CcSEcCtD
Pemetrexed—Shock—Doxorubicin—lung cancer	9.31e-06	0.000223	CcSEcCtD
Pemetrexed—Nervous system disorder—Doxorubicin—lung cancer	9.28e-06	0.000222	CcSEcCtD
Pemetrexed—Thrombocytopenia—Doxorubicin—lung cancer	9.26e-06	0.000222	CcSEcCtD
Pemetrexed—Skin disorder—Doxorubicin—lung cancer	9.19e-06	0.00022	CcSEcCtD
Pemetrexed—Anorexia—Doxorubicin—lung cancer	9.02e-06	0.000216	CcSEcCtD
Pemetrexed—Nausea—Docetaxel—lung cancer	9e-06	0.000215	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Methotrexate—lung cancer	8.93e-06	0.000214	CcSEcCtD
Pemetrexed—Urticaria—Methotrexate—lung cancer	8.68e-06	0.000208	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—lung cancer	8.64e-06	0.000207	CcSEcCtD
Pemetrexed—Abdominal pain—Methotrexate—lung cancer	8.64e-06	0.000207	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Doxorubicin—lung cancer	8.62e-06	0.000206	CcSEcCtD
Pemetrexed—Dyspnoea—Doxorubicin—lung cancer	8.43e-06	0.000202	CcSEcCtD
Pemetrexed—Dyspepsia—Doxorubicin—lung cancer	8.33e-06	0.000199	CcSEcCtD
Pemetrexed—Decreased appetite—Doxorubicin—lung cancer	8.22e-06	0.000197	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Doxorubicin—lung cancer	8.17e-06	0.000195	CcSEcCtD
Pemetrexed—Fatigue—Doxorubicin—lung cancer	8.16e-06	0.000195	CcSEcCtD
Pemetrexed—Constipation—Doxorubicin—lung cancer	8.09e-06	0.000194	CcSEcCtD
Pemetrexed—Pain—Doxorubicin—lung cancer	8.09e-06	0.000194	CcSEcCtD
Pemetrexed—Hypersensitivity—Methotrexate—lung cancer	8.05e-06	0.000193	CcSEcCtD
Pemetrexed—DHFR—Disease—ENO2—lung cancer	7.98e-06	0.00039	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GCLC—lung cancer	7.98e-06	0.000389	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP2A6—lung cancer	7.98e-06	0.000389	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ABCB1—lung cancer	7.93e-06	0.000387	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PPP2R1B—lung cancer	7.93e-06	0.000387	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SMARCA4—lung cancer	7.93e-06	0.000387	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	7.92e-06	0.000387	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGFR1—lung cancer	7.87e-06	0.000384	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—UGT1A1—lung cancer	7.86e-06	0.000384	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTA4—lung cancer	7.85e-06	0.000383	CbGpPWpGaD
Pemetrexed—Asthenia—Methotrexate—lung cancer	7.84e-06	0.000188	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—TYMS—lung cancer	7.79e-06	0.00038	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HIF1A—lung cancer	7.75e-06	0.000379	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	7.74e-06	0.000378	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Doxorubicin—lung cancer	7.74e-06	0.000185	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—lung cancer	7.73e-06	0.000185	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—GSTM1—lung cancer	7.7e-06	0.000376	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTA2—lung cancer	7.65e-06	0.000373	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—BIRC5—lung cancer	7.63e-06	0.000373	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—RAF1—lung cancer	7.6e-06	0.000371	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GNG11—lung cancer	7.58e-06	0.00037	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ENO1—lung cancer	7.56e-06	0.000369	CbGpPWpGaD
Pemetrexed—Urticaria—Doxorubicin—lung cancer	7.52e-06	0.00018	CcSEcCtD
Pemetrexed—SLC46A1—Disease—APOA1—lung cancer	7.48e-06	0.000365	CbGpPWpGaD
Pemetrexed—Body temperature increased—Doxorubicin—lung cancer	7.48e-06	0.000179	CcSEcCtD
Pemetrexed—Abdominal pain—Doxorubicin—lung cancer	7.48e-06	0.000179	CcSEcCtD
Pemetrexed—Diarrhoea—Methotrexate—lung cancer	7.48e-06	0.000179	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—TERT—lung cancer	7.39e-06	0.000361	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTA1—lung cancer	7.38e-06	0.00036	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—RB1—lung cancer	7.37e-06	0.00036	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CG—lung cancer	7.34e-06	0.000358	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	7.32e-06	0.000357	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP1A1—lung cancer	7.3e-06	0.000357	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCC3—lung cancer	7.3e-06	0.000356	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ENO1—lung cancer	7.26e-06	0.000354	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ERCC2—lung cancer	7.24e-06	0.000354	CbGpPWpGaD
Pemetrexed—Dizziness—Methotrexate—lung cancer	7.23e-06	0.000173	CcSEcCtD
Pemetrexed—DHFR—Metabolism—ALDOA—lung cancer	7.22e-06	0.000352	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKR1C1—lung cancer	7.07e-06	0.000345	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PTEN—lung cancer	7.01e-06	0.000342	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NCOA3—lung cancer	7.01e-06	0.000342	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—POMC—lung cancer	6.99e-06	0.000341	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Doxorubicin—lung cancer	6.97e-06	0.000167	CcSEcCtD
Pemetrexed—Vomiting—Methotrexate—lung cancer	6.95e-06	0.000166	CcSEcCtD
Pemetrexed—Rash—Methotrexate—lung cancer	6.89e-06	0.000165	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—lung cancer	6.88e-06	0.000165	CcSEcCtD
Pemetrexed—TYMS—Metabolism—UGT1A1—lung cancer	6.86e-06	0.000335	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KIT—lung cancer	6.83e-06	0.000333	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—APC—lung cancer	6.83e-06	0.000333	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ADCY1—lung cancer	6.82e-06	0.000333	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCG2—lung cancer	6.82e-06	0.000333	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CREBBP—lung cancer	6.81e-06	0.000332	CbGpPWpGaD
Pemetrexed—Asthenia—Doxorubicin—lung cancer	6.79e-06	0.000162	CcSEcCtD
Pemetrexed—DCK—Metabolism—CYP2E1—lung cancer	6.78e-06	0.000331	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGF—lung cancer	6.75e-06	0.00033	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APP—lung cancer	6.75e-06	0.000329	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	6.72e-06	0.000328	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NQO1—lung cancer	6.71e-06	0.000327	CbGpPWpGaD
Pemetrexed—Pruritus—Doxorubicin—lung cancer	6.69e-06	0.00016	CcSEcCtD
Pemetrexed—DHFR—Disease—FGF9—lung cancer	6.69e-06	0.000327	CbGpPWpGaD
Pemetrexed—GART—Metabolism—EP300—lung cancer	6.69e-06	0.000327	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HPGDS—lung cancer	6.69e-06	0.000326	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ENO2—lung cancer	6.69e-06	0.000326	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPP2R1B—lung cancer	6.64e-06	0.000324	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GNG11—lung cancer	6.62e-06	0.000323	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—RB1—lung cancer	6.59e-06	0.000322	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	6.5e-06	0.000317	CbGpPWpGaD
Pemetrexed—Nausea—Methotrexate—lung cancer	6.49e-06	0.000155	CcSEcCtD
Pemetrexed—DHFR—Metabolism—GSTT1—lung cancer	6.48e-06	0.000317	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—lung cancer	6.48e-06	0.000317	CbGpPWpGaD
Pemetrexed—Diarrhoea—Doxorubicin—lung cancer	6.47e-06	0.000155	CcSEcCtD
Pemetrexed—ATIC—Metabolism—PIK3CD—lung cancer	6.45e-06	0.000315	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—RB1—lung cancer	6.43e-06	0.000314	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—BRAF—lung cancer	6.42e-06	0.000313	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2A6—lung cancer	6.41e-06	0.000313	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GCLC—lung cancer	6.41e-06	0.000313	CbGpPWpGaD
Pemetrexed—DHFR—Disease—JUNB—lung cancer	6.39e-06	0.000312	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—lung cancer	6.37e-06	0.000311	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6R—lung cancer	6.34e-06	0.00031	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CREBBP—lung cancer	6.33e-06	0.000309	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALDOA—lung cancer	6.3e-06	0.000308	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—APOA1—lung cancer	6.27e-06	0.000306	CbGpPWpGaD
Pemetrexed—Dizziness—Doxorubicin—lung cancer	6.26e-06	0.00015	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—lung cancer	6.24e-06	0.000305	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NCOA3—lung cancer	6.11e-06	0.000299	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ENO1—lung cancer	6.08e-06	0.000297	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—STK11—lung cancer	6.04e-06	0.000295	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAP2K1—lung cancer	6.04e-06	0.000295	CbGpPWpGaD
Pemetrexed—Vomiting—Doxorubicin—lung cancer	6.02e-06	0.000144	CcSEcCtD
Pemetrexed—SLC46A1—Disease—PIK3CD—lung cancer	6e-06	0.000293	CbGpPWpGaD
Pemetrexed—Rash—Doxorubicin—lung cancer	5.97e-06	0.000143	CcSEcCtD
Pemetrexed—Dermatitis—Doxorubicin—lung cancer	5.96e-06	0.000143	CcSEcCtD
Pemetrexed—TYMS—Metabolism—ADCY1—lung cancer	5.95e-06	0.00029	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCG2—lung cancer	5.95e-06	0.00029	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ENO2—lung cancer	5.83e-06	0.000285	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HPGDS—lung cancer	5.83e-06	0.000285	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPP2R1B—lung cancer	5.8e-06	0.000283	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—lung cancer	5.8e-06	0.000283	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—RB1—lung cancer	5.75e-06	0.000281	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CG—lung cancer	5.72e-06	0.000279	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—lung cancer	5.71e-06	0.000279	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTT1—lung cancer	5.66e-06	0.000276	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—lung cancer	5.66e-06	0.000276	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CB—lung cancer	5.63e-06	0.000275	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MDM2—lung cancer	5.62e-06	0.000274	CbGpPWpGaD
Pemetrexed—Nausea—Doxorubicin—lung cancer	5.62e-06	0.000134	CcSEcCtD
Pemetrexed—DHFR—Disease—FOXO3—lung cancer	5.6e-06	0.000273	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCLC—lung cancer	5.59e-06	0.000273	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2A6—lung cancer	5.59e-06	0.000273	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTP1—lung cancer	5.59e-06	0.000273	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTGS2—lung cancer	5.57e-06	0.000272	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.49e-06	0.000268	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CCND1—lung cancer	5.48e-06	0.000267	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP2E1—lung cancer	5.45e-06	0.000266	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—POMC—lung cancer	5.44e-06	0.000266	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CAT—lung cancer	5.44e-06	0.000266	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NQO1—lung cancer	5.39e-06	0.000263	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MDM2—lung cancer	5.38e-06	0.000263	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—RAF1—lung cancer	5.36e-06	0.000262	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CREBBP—lung cancer	5.3e-06	0.000259	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—lung cancer	5.3e-06	0.000259	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ENO1—lung cancer	5.3e-06	0.000259	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN1A—lung cancer	5.3e-06	0.000259	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ABCB1—lung cancer	5.29e-06	0.000258	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MTOR—lung cancer	5.23e-06	0.000256	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CB—lung cancer	5.23e-06	0.000256	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CD4—lung cancer	5.22e-06	0.000255	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TYMS—lung cancer	5.2e-06	0.000254	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTGS2—lung cancer	5.19e-06	0.000253	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTM1—lung cancer	5.14e-06	0.000251	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—lung cancer	5.06e-06	0.000247	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—EP300—lung cancer	5.04e-06	0.000246	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CD—lung cancer	5.03e-06	0.000246	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—lung cancer	4.96e-06	0.000242	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HES1—lung cancer	4.96e-06	0.000242	CbGpPWpGaD
Pemetrexed—GART—Metabolism—PIK3CA—lung cancer	4.95e-06	0.000242	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MDM2—lung cancer	4.91e-06	0.00024	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CCND1—lung cancer	4.9e-06	0.000239	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1A1—lung cancer	4.87e-06	0.000238	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PTEN—lung cancer	4.86e-06	0.000237	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—STK11—lung cancer	4.86e-06	0.000237	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ERCC2—lung cancer	4.83e-06	0.000236	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CCND1—lung cancer	4.78e-06	0.000233	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP2E1—lung cancer	4.76e-06	0.000232	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN1A—lung cancer	4.74e-06	0.000231	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NQO1—lung cancer	4.7e-06	0.00023	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERCC2—lung cancer	4.64e-06	0.000226	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—EP300—lung cancer	4.64e-06	0.000226	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—lung cancer	4.62e-06	0.000226	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB3—lung cancer	4.53e-06	0.000221	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—CDKN1A—lung cancer	4.53e-06	0.000221	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PTEN—lung cancer	4.52e-06	0.000221	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MAPK3—lung cancer	4.52e-06	0.000221	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—EP300—lung cancer	4.51e-06	0.00022	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTP1—lung cancer	4.49e-06	0.000219	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—EP300—lung cancer	4.4e-06	0.000215	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—lung cancer	4.39e-06	0.000214	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CB—lung cancer	4.38e-06	0.000214	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CAT—lung cancer	4.37e-06	0.000214	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TERT—lung cancer	4.35e-06	0.000212	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTGS2—lung cancer	4.34e-06	0.000212	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EP300—lung cancer	4.31e-06	0.000211	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CCND1—lung cancer	4.27e-06	0.000209	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCB1—lung cancer	4.25e-06	0.000208	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—STK11—lung cancer	4.24e-06	0.000207	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR1—lung cancer	4.22e-06	0.000206	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SRC—lung cancer	4.19e-06	0.000205	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—APOA1—lung cancer	4.18e-06	0.000204	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TYMS—lung cancer	4.18e-06	0.000204	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HIF1A—lung cancer	4.16e-06	0.000203	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN1A—lung cancer	4.13e-06	0.000202	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTM1—lung cancer	4.13e-06	0.000202	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—STAT3—lung cancer	4.04e-06	0.000197	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—lung cancer	4.04e-06	0.000197	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MAPK3—lung cancer	4.04e-06	0.000197	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NRAS—lung cancer	4.03e-06	0.000197	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APOA1—lung cancer	4.01e-06	0.000196	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MAPK3—lung cancer	3.94e-06	0.000192	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—EP300—lung cancer	3.93e-06	0.000192	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—lung cancer	3.93e-06	0.000192	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTP1—lung cancer	3.92e-06	0.000191	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1A1—lung cancer	3.92e-06	0.000191	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ERCC2—lung cancer	3.88e-06	0.00019	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MAPK3—lung cancer	3.86e-06	0.000189	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—lung cancer	3.83e-06	0.000187	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CAT—lung cancer	3.82e-06	0.000186	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CG—lung cancer	3.82e-06	0.000186	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PTEN—lung cancer	3.79e-06	0.000185	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—lung cancer	3.76e-06	0.000183	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCB1—lung cancer	3.71e-06	0.000181	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—lung cancer	3.68e-06	0.000179	CbGpPWpGaD
Pemetrexed—DHFR—Disease—APC—lung cancer	3.66e-06	0.000179	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KIT—lung cancer	3.66e-06	0.000179	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—POMC—lung cancer	3.63e-06	0.000177	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGF—lung cancer	3.62e-06	0.000177	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—EP300—lung cancer	3.61e-06	0.000176	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTM1—lung cancer	3.6e-06	0.000176	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CREBBP—lung cancer	3.54e-06	0.000173	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MAPK3—lung cancer	3.52e-06	0.000172	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KRAS—lung cancer	3.47e-06	0.00017	CbGpPWpGaD
Pemetrexed—DHFR—Disease—BRAF—lung cancer	3.44e-06	0.000168	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PIK3CA—lung cancer	3.43e-06	0.000167	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—lung cancer	3.43e-06	0.000167	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1A1—lung cancer	3.42e-06	0.000167	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6R—lung cancer	3.4e-06	0.000166	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CREBBP—lung cancer	3.4e-06	0.000166	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ERCC2—lung cancer	3.39e-06	0.000165	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APOA1—lung cancer	3.36e-06	0.000164	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CD—lung cancer	3.35e-06	0.000164	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—lung cancer	3.31e-06	0.000162	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAP2K1—lung cancer	3.24e-06	0.000158	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—lung cancer	3.23e-06	0.000158	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CD—lung cancer	3.22e-06	0.000157	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PIK3CA—lung cancer	3.19e-06	0.000156	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CG—lung cancer	3.07e-06	0.00015	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—lung cancer	2.95e-06	0.000144	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—APOA1—lung cancer	2.93e-06	0.000143	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CB—lung cancer	2.92e-06	0.000143	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—POMC—lung cancer	2.92e-06	0.000143	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTGS2—lung cancer	2.9e-06	0.000141	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MDM2—lung cancer	2.88e-06	0.000141	CbGpPWpGaD
Pemetrexed—DHFR—Disease—RAF1—lung cancer	2.87e-06	0.00014	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CREBBP—lung cancer	2.84e-06	0.000139	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—lung cancer	2.84e-06	0.000139	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—lung cancer	2.82e-06	0.000138	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—lung cancer	2.81e-06	0.000137	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MTOR—lung cancer	2.81e-06	0.000137	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CB—lung cancer	2.81e-06	0.000137	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—lung cancer	2.8e-06	0.000137	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CD4—lung cancer	2.8e-06	0.000137	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTGS2—lung cancer	2.78e-06	0.000136	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CD—lung cancer	2.7e-06	0.000132	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CG—lung cancer	2.68e-06	0.000131	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PIK3CA—lung cancer	2.67e-06	0.00013	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—lung cancer	2.66e-06	0.00013	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—lung cancer	2.61e-06	0.000127	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—POMC—lung cancer	2.55e-06	0.000124	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PTEN—lung cancer	2.53e-06	0.000123	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CREBBP—lung cancer	2.48e-06	0.000121	CbGpPWpGaD
Pemetrexed—DHFR—Disease—CDKN1A—lung cancer	2.43e-06	0.000119	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTEN—lung cancer	2.42e-06	0.000118	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—EP300—lung cancer	2.41e-06	0.000118	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CD—lung cancer	2.35e-06	0.000115	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CB—lung cancer	2.35e-06	0.000115	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTGS2—lung cancer	2.33e-06	0.000114	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—lung cancer	2.32e-06	0.000113	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EP300—lung cancer	2.31e-06	0.000113	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SRC—lung cancer	2.25e-06	0.00011	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—lung cancer	2.18e-06	0.000107	CbGpPWpGaD
Pemetrexed—DHFR—Disease—STAT3—lung cancer	2.17e-06	0.000106	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NRAS—lung cancer	2.16e-06	0.000106	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MAPK3—lung cancer	2.07e-06	0.000101	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CB—lung cancer	2.05e-06	0.0001	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTGS2—lung cancer	2.03e-06	9.92e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PTEN—lung cancer	2.03e-06	9.91e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—lung cancer	2.02e-06	9.84e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—lung cancer	1.97e-06	9.62e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—EP300—lung cancer	1.94e-06	9.46e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KRAS—lung cancer	1.86e-06	9.09e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PIK3CA—lung cancer	1.78e-06	8.7e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PTEN—lung cancer	1.77e-06	8.65e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PIK3CA—lung cancer	1.71e-06	8.35e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—EP300—lung cancer	1.69e-06	8.25e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—lung cancer	1.58e-06	7.73e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—lung cancer	1.51e-06	7.4e-05	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—lung cancer	1.46e-06	7.11e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PIK3CA—lung cancer	1.43e-06	6.99e-05	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—lung cancer	1.4e-06	6.82e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PIK3CA—lung cancer	1.25e-06	6.1e-05	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—lung cancer	1.17e-06	5.71e-05	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—lung cancer	1.02e-06	4.99e-05	CbGpPWpGaD
